clinical trials

ACC 2023 – the market tries to take Medtronic’s pulse
ACC 2023 – the market tries to take Medtronic’s pulse
EP Vantage
ACC
Medtronic
pulsed field ablation
PulseSelect
clinical trials
devices
Medtech
Flag link:
Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients With Acute Coronary Syndrome
Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients With Acute Coronary Syndrome
Yahoo/Benzinga
Amarin
Vascepa
Vazkepa
acute coronary syndrome
clinical trials
Flag link:
AstraZeneca, Daiichi Sankyo tease new Enhertu data — but details remain under wraps
AstraZeneca, Daiichi Sankyo tease new Enhertu data — but details remain under wraps
Endpoints
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
Flag link:
Merck’s oral cholesterol-lowering drug shows similar efficacy to injectable predecessors as it moves to PhIII: #ACC23
Merck’s oral cholesterol-lowering drug shows similar efficacy to injectable predecessors as it moves to PhIII: #ACC23
Endpoints
Merck
PAH
clinical trials
MK-0616
Flag link:
Praxis Shares Fall 48% Following Mixed Data for Essential Tremor Candidate
Praxis Shares Fall 48% Following Mixed Data for Essential Tremor Candidate
BioSpace
Praxis Precision Medicines
ulixacaltamide
clinical trials
essential tremor
Flag link:
Incyte Abandons Phase III Trial for Myelofibrosis Treatment
Incyte Abandons Phase III Trial for Myelofibrosis Treatment
BioSpace
Incyte
clinical trials
myelofibrosis
Jakafi
Flag link:
Mineralys reports positive data from trial of lorundrostat for hypertension
Mineralys reports positive data from trial of lorundrostat for hypertension
Clinical Trials Arena
Mineralys Therapeutics
clinical trials
hypertension
lorundrostat
Flag link:
Sanofi’s clinical trial of hemophilia A therapy in children meets endpoint
Sanofi’s clinical trial of hemophilia A therapy in children meets endpoint
Clinical Trials Arena
Sanofi
clinical trials
hemophilia A
Altuviiio
Flag link:
Roche, Exelixis Suffer Another Late-Stage Cancer Combo Failure
Roche, Exelixis Suffer Another Late-Stage Cancer Combo Failure
BioSpace
Roche
Exelixis
renal cell carcinoma
Tecentriq
Cabometyx
clinical trials
Flag link:
FDA rejects Covid-19 drug over uncertainties around small trial
FDA rejects Covid-19 drug over uncertainties around small trial
Endpoints
Veru
clinical trials
COVID-19
ARDS
sabizabulin
Flag link:
Praxis share price halved after essential tremor fail, but biotech still plans phase 3
Praxis share price halved after essential tremor fail, but biotech still plans phase 3
Fierce Biotech
Praxis Precision Medicines
clinical trials
essential tremors
ulixacaltamide
Flag link:
Spotlight – What is next in Nash
Spotlight – What is next in Nash
EP Vantage
NASH
clinical trials
89Bio
Arrowhead Pharmaceuticals
Can-Fite BioPharma
Ewopharma
Hepagene Therapeutics
JNJ
Ligand Pharmaceuticals
Madrigal Pharmaceuticals
Merck
NGM Biopharmaceuticals
NorthSea Therapeutics
Novartis
Sagimet Biosciences
Terns Pharmaceuticals
Viking Therapeutics
Flag link:
Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients
Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients
BioPharma Dive
Bristol Myers Squibb
JNJ
clinical trials
Librexia
bloodthinners
Flag link:
Atom Bioscience reports positive Phase IIa chronic gout therapy trial data
Atom Bioscience reports positive Phase IIa chronic gout therapy trial data
Clinical Trials Arena
Atom Bioscience
gout
clinical trials
ABP-671
Flag link:
Atea dumps dengue drug as 'unevaluable' endpoint causes timelines, forecast costs to spiral
Atea dumps dengue drug as 'unevaluable' endpoint causes timelines, forecast costs to spiral
Fierce Biotech
Atea Pharmaceuticals
dengue
clinical trials
AT-752
Flag link:
Aldeyra reports positive data from dry eye disease therapy trial
Aldeyra reports positive data from dry eye disease therapy trial
Clinical Trials Arena
Aldeyra Therapeutics
clinical trials
reproxalap
dry eye disease
Flag link:
CSL's Phase 3 Study Shows First-In-Class Garadacimab Provides Patients with Significant HAE Attack Prevention with Monthly Dosing
CSL's Phase 3 Study Shows First-In-Class Garadacimab Provides Patients with Significant HAE Attack Prevention with Monthly Dosing
Drugs.com
CSL
clinical trials
garadacimab
HAE
Flag link:
23andMe doses first patient in ph2a anti-tumour monotherapy
23andMe doses first patient in ph2a anti-tumour monotherapy
Pharmaphorum
23andMe
clinical trials
solid tumors
23ME-00610
Flag link:
Merck reports two Phase 3 study misses for Keytruda
Merck reports two Phase 3 study misses for Keytruda
BioPharma Dive
Merck
clinical trials
Keytruda
prostate cancer
lung cancer
Flag link:
Acumen reveals late-stage clinical trial plans in early Alzheimer’s disease
Acumen reveals late-stage clinical trial plans in early Alzheimer’s disease
Clinical Trials Arena
Acumen Pharmaceuticals
clinical trials
Alzheimer's disease
ACU193
monoclonal antibodies
Flag link:

Pages